Clinical trial · Interventional
Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial
Fuzhegn Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial
NCT06324825CI-TRIAL-00075302unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Fuzheng Nizeng Formula (FZNZ) is derived from the classic formula Liujunzi Decoction. Former pilot study found that FZNZ promoted the recovery of gastric atrophy and relieve the relative symptoms. This study is to evaluate its efficacy for chronic atrophic gastritis with low-grade intraepithelial neoplasia, compared with positive control Molduodan granule.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Atrophic Gastritis With Low-grade Intraepithelial Neoplasia | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fuzhegn Nizeng Decoction | Drug | — | UNRESOLVED |
| Moluodan granules | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Fuzhegn Nizeng Formula
- interventionNames
- Drug: Fuzhegn Nizeng Decoction
- type
- ACTIVE_COMPARATOR
- label
- Moluodan patient medicine
- interventionNames
- Drug: Moluodan granules
Primary outcomes (1)
- measure
- Recovery rate of Low-grade Intraepithelial Neoplasia
- timeFrame
- The 180 days after drug administration.
- description
- Stomach biopsy will be taken after drug administration completion.
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia diagnosed by endoscopy and stomach biopsy. * Helicobacter pylori negative. * TCM syndrome is spleen-stomach deficiency with blood stasis and phelgm. Exclusion Criteria: * History of gastric surgery. * Combined with malignant tumor. * History of mental illness. * Allergy to any components of the drug use in the study. * Planning to pregnancy, or pregnant woman and lactating woman.
References
Publications (0)
Data not yet available
No reference posted for this study.